MedPath

Home-based Transcranial Direct Current Stimulation (tDCS) to Promote Social Communication and Behaviour in Children With Autism Spectrum Disorder (ASD)

Phase 2
Recruiting
Conditions
Autism Spectrum Disorder
Interventions
Device: At-home transcranial direct current stimulation (tDCS)
Device: Sham at-home tDCS
Registration Number
NCT06129058
Lead Sponsor
Holland Bloorview Kids Rehabilitation Hospital
Brief Summary

Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation that can be delivered in a home setting. It is a safe and tolerable intervention that has shown promise for improving positive social communication and self-regulation in youth with Autism Spectrum Disorder (ASD). Children and youth with ASD will be randomized to At-home tDCS or sham control stimulation for 3 weeks. We will measure the effect of At-home tDCS on the brain mechanisms and clinical measures of social communication and self-regulation..

Detailed Description

Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation that can be delivered in a home setting. It is a safe and tolerable intervention that has shown promise for improving positive social communication and self-regulation in youth with Autism Spectrum Disorder (ASD). Previous studies have been limited by small and poorly represented samples, lack of experimental control, insufficient follow-up periods, inadequate blinding and the absence of neural outcome measures. Our project will collect pilot data on the effects of home-based tDCS on reducing disruptive behaviours in youth with ASD, in order to inform the design of a follow-up full-scale clinical trial. We will recruit youth with ASD who experience clinically significant difficulties with social communication and self-regulation. Participants will be randomized to tDCS or sham control stimulation for 3 weeks. We will measure the effect of tDCS on the brain mechanisms and clinical measures of social communication and self-regulation..

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Children with a diagnosis of autism spectrum disorder and self-regulation impairment or social communication challenges
  • Able to participate in tDCS
Exclusion Criteria
  • Children with contraindications to tDCS (history of seizures, family history of seizures, metal implants)
  • Co-existing neurological conditions (epilepsy, stroke, etc.)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
tDCSAt-home transcranial direct current stimulation (tDCS)active tDCS
ShamSham at-home tDCSsham tDCS
Primary Outcome Measures
NameTimeMethod
Recruitmentweeks 1-18

Recruitment rates of 4 participants/month are achieved with a ≥ 20% response rate

Attritionweeks 1-18

Attrition rates of less than 10% (i.e., ≥90% of participants successfully complete assessments).

Blindingweeks 1-18

Blinding of participants and their parents/caregivers and required study team using a Blinding Questionnaire indicating the perceived group membershipmembers will be assessed using a Blinding Questionnaire indicating the perceived group membership (tDCS/Sham)

Adherenceweeks 1-18

90% of participants who complete assessment achieve the target intensity and dose (15 tDCS sessions)

Secondary Outcome Measures
NameTimeMethod
Inhibitory control0 weeks, 6 weeks, 18 weeks

change in Go/No Task Response Time

Overall Clinical Change0 weeks, 6 weeks, 18 weeks

Clinical Global Impression scale - 1 item on a scale from 0-7 (a change of 0.5 indicates a clinical impact of significance)

Magnetic Resonance Imaging (MRI)0 weeks, 6 weeks, 18 weeks

Diffusion imaging - change in fractional anisotropy, Resting State functional MRI change in Blood Oxygen Level Dependent (BOLD) signal

Trial Locations

Locations (1)

Holland Bloorview Kids Rehabilitation Hosptail

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath